COVID: WHO seeks more data from Sputnik V makers to grant emergency Use Listing

Published On 2021-09-13 08:01 GMT   |   Update On 2021-09-13 08:01 GMT
Advertisement

New Delhi: The World Health Organisation has sought some more data from Russia's Gamaleya National Research Institute of Epidemiology and Microbiology, developer of COVID-19 vaccine Sputnik V for according Emergency Use Listing status for the jab. Sputnik V is currently manufactured in India and being sold by Dr Reddy's Laboratories under Emergency Use Authorisation route.

According to WHO website, though several meetings were held as part of the process for EUL, the status of assessment column says "On hold, awaiting completion of rolling submission".
Advertisement
"Anticipated date will be set once all data is submitted and follow-up of inspection observations completed," WHO said on the decision date for EUL.
Back home, Panacea Biotec supplied the first shipment of the second component of the Russian Sputnik V vaccine manufactured by it for sale in India on September 7. This is the first batch of the second component produced and supplied by the company in India, the drug firm and the Russian Direct Investment Fund (RDIF) had said in a joint statement.
RDIF has tied up with six Indian drug makers to manufacture Sputnik V and their supplies are expected to roll out by August or September, as senior official of Dr Reddy's had said earlier. The global health body is currently reviewing Bharat Biotech's application for an Emergency Use Listing of its Covid-19 vaccine Covaxin.

Read also: Sputnik Light gets emergency use nod in Philippines




Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News